Altre lingue Psyence Group Inc.

Azioni

PSYG

CA74449Q1063

Mercato chiuso - Canadian Securities Exchange Altri mercati azionari 16:24:00 24/06/2024			Variaz. 5gg	Var. 1 gen.
0,015 ^CAD	-25,00%		-25,00%	-70,00%

26/03	Un acquirente non dichiarato ha completato l'acquisizione di Mind Health (Pty) Ltd e Psyence Uk Group Ltd da Psyence Group Inc. (CNSX:PSYG).	CI
11/03	Psyence Group Inc. annuncia le dimissioni di Neil Maresky dalla carica di CEO	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Psyence : NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial	06/05
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial	16/04
Psyence Group Closes Strategic Restructuring of Its Non-Clinical Business	26/03
Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business	26/03
An undisclosed buyer completed the acquisition of Mind Health Ltd and Psyence Uk Group Ltd from Psyence Group Inc..	26/03
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study	12/03
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study	12/03
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division	11/03
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division	11/03
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division	11/03
Psyence Group Inc. Announces Resignation of Neil Maresky as CEO	11/03
Psyence Group Inc. Announces CFO Changes	11/03
Psyence Group Inc. Announces Board Resignations	11/03
An undisclosed buyer entered into a conditional agreement to acquire Mind Health Ltd and Psyence Uk Group Ltd from Psyence Group Inc. for CAD 1 million.	11/03
Psyence Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	28/02
Psyence Biomedical Approved to List on Nasdaq Following Completion of Business Combination With Newcourt Acquisition Corp	26/01
Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp	26/01
Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp	25/01
Psyence Group Inc Subsidiary Psyence Biomedical Ltd. announces signing of definitive agreement for a convertible note in connection with planned business combination	16/01
Psyence Group Inc. Announces Resignation of Marvin Singer as Board Member	20/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Psyence Group Inc.

Azioni

PSYG

CA74449Q1063

Altre lingue

Filtri